IP No. 602289 The disclosure relates to iron(III) &bgr;-ketoamide complex compounds of formula I and pharmaceutical compounds comprising same for use as medicaments, in particular for the treatment and/or for the prophylaxis of iron deficiency symptoms and iron deficiency anemias. Compounds of the disclosure include: Tris-(3-oxobutaneamide)-iron(III) complex Tris-(N,N-dimethyl-3-oxobutaneamide)-iron(III) complex Tris-(N-methyl-3-oxobutaneamide)-iron(III) complex Tris(N-butyl-3-oxobutaneamide)-iron(III) complex Tris(N,N-dibutyl-3-oxobutaneamide)-iron(III) complex Tris-(1-(piperidin-1-yl)-butane-1,3-dione)-iron(III) complex Tris(3-oxoheptaneamide)-iron(III) complex Tris(N-methyl-3-oxoheptaneamide)-iron(III) complex Tris-(N,N-bis-(2-hydroxyethyl)-3-oxobutaneamide)-iron(III) complex Tris-(4-Methoxy-1-(morpholin-4-yl)butane-1,3-dione)-iron(III)-complex Tris-(3-acetyl-1-methylpyrrolidin-2-one)-iron(III)-complex Tris-(Ethyl (1-methyl-2-oxopyrrolidin-3-yl)(oxo)acetate)-iron(III)-complex Tris-(ethyl (1-methyl-2-oxopiperidin-3-yl)(oxo)acetate)-iron(III)-complex And Tris-(N-(2-hydroxypropyl)-3-oxobutanamide)-iron(III)-complex